Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EBIT Growth

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 8.066.3197.66-47.11-18.43

What is the latest EBIT Growth ratio of BLISS GVS PHARMA ?

The latest EBIT Growth ratio of BLISS GVS PHARMA is 8.06 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar20258.06
Mar20246.31
Mar202397.66
Mar2022-47.11
Mar2021-18.43

How is EBIT Growth of BLISS GVS PHARMA Trending?

Years EBIT Growth % Change
Mar2025 8.06
27.73
Mar2024 6.31
-93.54
Mar2023 97.66
Positive
Mar2022 -47.11
Negative
Mar2021 -18.43 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EBIT Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,792.1 Cr 1.7% 9.3% 32.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,370.0 Cr 1.2% 5.5% 0.3% Stock Analytics
DIVIS LABORATORIES ₹168,802.0 Cr -1.8% -3.1% 8.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,841.0 Cr -2% 2.8% 19.2% Stock Analytics
CIPLA ₹121,481.0 Cr -0.7% -8.6% 2.7% Stock Analytics
DR REDDYS LABORATORIES ₹102,220.0 Cr -1.5% -4.3% 2.5% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

1.7%

9.3%

32.4%

SENSEX

-0.1%

0.6%

9.8%


You may also like the below Video Courses